Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Shares of Abbott Laboratories ABT rallied 1.07% to $122.55 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.67% to 6,886.68 ...

It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has declined ...

Disclosed on November 25, Eric Shroff, Senior Vice President at Abbott Laboratories (NYSE:ABT), executed a substantial insider sell as per the latest SEC filing. What Happened: Shroff's decision to ...

The main point of investing for the long term is to make money. But more than that, you probably want to see it ...

Shares of Abbott Laboratories ABT shed 1.41% to $127.63 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.63% to 6,629.07 and ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Discover why Abbott Laboratories (ABT) earns a buy rating with strong fundamentals, dividend growth, and growth prospects.

Abbott Laboratories ABT recently received FDA approval for its Volt PFA System to treat patients battling atrial fibrillation ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), ...